
Processa Pharmaceuticals PCSA
$ 3.03
2.36%
Annual report 2025
added 03-18-2026
Processa Pharmaceuticals PEG Ratio 2011-2026 | PCSA
Annual PEG Ratio Processa Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.000309 | -0.000032 | -0.000344 | -0.000016 | -0.178 | 0.00897 | -95 K | 0.476 | -1.01 | -0.0548 | -0.0241 | 0.367 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.476 | -95 K | -7.92 K |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | ||
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 3.88 | 3.89 % | $ 9.34 B | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
-0.955 | $ 323.46 | -2.98 % | $ 42.4 B | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Burford Capital Limited
BUR
|
-0.568 | $ 4.7 | -0.63 % | $ 766 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Cabaletta Bio
CABA
|
-0.01 | $ 3.55 | 4.26 % | $ 357 M | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
Aligos Therapeutics
ALGS
|
0.0282 | $ 8.1 | 9.16 % | $ 80.1 M | ||
|
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 21.91 | 1.04 % | $ 1.02 B | ||
|
CymaBay Therapeutics
CBAY
|
-24.1 | - | - | $ 3.45 B | ||
|
BioNTech SE
BNTX
|
-12.8 | $ 101.31 | 1.85 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 3.07 | -3.15 % | $ 5.05 M | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
Galectin Therapeutics
GALT
|
0.235 | $ 2.3 | -10.35 % | $ 147 M | ||
|
ContraFect Corporation
CFRX
|
-0.000085 | - | -5.16 % | $ 5.39 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
1.02 | $ 1.39 | -10.32 % | $ 357 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
Grifols, S.A.
GRFS
|
-0.077 | $ 8.57 | -1.44 % | $ 6.83 B | ||
|
Aquestive Therapeutics
AQST
|
-0.64 | $ 4.21 | -0.71 % | $ 450 M | ||
|
Arcutis Biotherapeutics
ARQT
|
0.0316 | $ 23.86 | -2.93 % | $ 3.04 B | ||
|
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
0.69 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.54 | 3.02 % | $ 410 M | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B | ||
|
Immatics N.V.
IMTX
|
2.14 K | $ 10.75 | -2.27 % | $ 676 M | ||
|
Checkpoint Therapeutics
CKPT
|
-0.00928 | - | - | $ 169 M | ||
|
Incyte Corporation
INCY
|
0.135 | $ 95.06 | -2.11 % | $ 18.6 B | ||
|
Caladrius Biosciences
CLBS
|
-0.00197 | - | -16.75 % | $ 25.8 M | ||
|
AVROBIO
AVRO
|
0.068 | - | 1083.1 % | $ 745 M | ||
|
Clearside Biomedical
CLSD
|
-0.00335 | - | - | $ 25.3 M |